van der Knaap, Noa https://orcid.org/0000-0002-7067-3345
Franx, Bart A. A. https://orcid.org/0000-0002-6410-3805
Majoie, Charles B. L. M. https://orcid.org/0000-0002-7600-9568
van der Lugt, Aad https://orcid.org/0000-0002-6159-2228
Dijkhuizen, Rick M. https://orcid.org/0000-0002-4623-4078
,
Funding for this research was provided by:
Dutch Heart Foundation (CVON2015-01)
Dutch Heart Foundation (CVON2015-01)
Dutch Heart Foundation (CVON2015-01)
Dutch Heart Foundation (CVON2015-01)
Brain Foundation, Netherlands (HA2015.01.06)
Brain Foundation, Netherlands (HA2015.01.06)
Brain Foundation, Netherlands (HA2015.01.06)
Brain Foundation, Netherlands (HA2015.01.06)
Ministerie van Economische Zaken (LSHM17016)
Ministerie van Economische Zaken (LSHM17016)
Ministerie van Economische Zaken (LSHM17016)
Ministerie van Economische Zaken (LSHM17016)
Article History
Received: 28 October 2022
Revised: 22 December 2022
Accepted: 23 December 2022
First Online: 19 January 2023
Declarations
:
: N.v.d.K. and B.A.A.F. have no relevant financial or non-financial interests to disclose. C.B.L.M.M. received funds from CVON/Dutch Heart Foundation, the European Commission, Healthcare Evaluation Netherlands, TWIN Foundation and Stryker (unrelated to this project; all paid to institution) and is shareholder of Nicolab. A.v.d.L. received funds from CVON/Dutch Heart Foundation, the European Commission, Dutch Brain Foundation, Stryker, Medtronic, Penumbra, Cerenovus, Thrombolytic Science (unrelated to this project; all paid to the institution) and he serves on the DSMB of ESCAPE-NEXT. R.M.D. received funds from ZonMw, the European Commission, the Dutch Research Council (NWO) and Open Technology Programme (TTW; partly financed by NWO), and is an editorial board member of Translational Stroke Research.
: The funding sources were not involved in study design, monitoring, data collection, statistical analyses, interpretation of results, or manuscript writing.